
Research highlights benefits of hemp-derived CBD reported by patients with anxiety: reduced anxiety, better sleep, and improved mood.
Nonpsychoactive Cannabinoids: Science, Safety, and Therapeutic Potential
Research highlights benefits of hemp-derived CBD reported by patients with anxiety: reduced anxiety, better sleep, and improved mood.
A new literature review highlights CBD’s potential in skin health, from acne to psoriasis, while exploring delivery challenges and future applications.
The FDA-funded study found that CBD was linked to elevated liver enzymes in some healthy adults, underscoring need for further safety research.
In the second part of this webinar coverage, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.
Here, we bring you our top five recent articles covering National CBD Day 2025, medical cannabis patients’ workers’ compensation, Trump looking into cannabis rescheduling, research studies on cannabis for sleep, and a clinical trial for CBD and insomnia.
In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.
Avecho Biotechnology Limited is looking to recruit more than 500 patients for a clinical trial evaluating the use of a pharmaceutical CBD product to treat insomnia.
In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD research.
In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD-related medical research.
Check out our exciting 2025 National CBD Day coverage!
Analysis of two coffee products revealed 70–80% less CBD in the brewed coffee than what was indicated on the label.
Data from a recent study discovered that THC labeling was more accurate in concentrate products than with cannabis flower.
Here, we bring you our top five recent articles covering medical cannabis in Texas, cease-and-desist letter response, pardons in Maryland, cannabis in Thailand, and research on autism and cannabis.
Results included improvements in aggression, hyperactivity, and communication, but a strong placebo effect was also observed.
A recent study found that CBD gummies may not have accurate labeling on how much the cannabinoid it contains.
The cannabinoids cannabidiol (CBD) and cannabidivarin (CBDV) showed antifungal activity in both in vivo tests and in vitro wound models.
A recent study highlighted potential benefits for CBD to provide relief from chronic pain.
Topically applied cannabinoids such as CBD and THC may offer significant benefits for people experiencing localized pain and dermatological conditions. This article explores these potential benefits as well as their mechanisms.
A recent study explored how vaporized cannabis consisting of a standardized THC and CBD formulation may help improve symptoms of MS patients.
The ointment containing CBD and CBG was evaluated for its effect on improvements in symptoms after an eight week period.
The study tested the effects of the pillowcases on the sleep quality and sleep duration in nurses, also testing for effects on mood and anxiety.
Researchers developed a CBD–phospholipid complex to enhance solubility, permeability, and bioavailability.
The two new CBD pet products are aimed at supporting aging pets with arthritis, anxiety, and reactivity.
Industry feedback is being considered in developing pathways to make CBD accessible – and safe – to treat minor health conditions without a prescription.
Researchers found CBD improved muscle endurance, mitochondrial function, and oxidative capacity, and more, with effects eliminated by antibiotics.